Early pegcetacoplan treatment results in significantly greater tissue preservation compared to delayed treatment, emphasizing ...
Pickleball's popularity surged, with a 311% increase in players since 2020, reaching 19.8 million in 2024. A cross-sectional ...
A key area of practice management and sustainability initiatives is ensuring that waste is reduced whenever possible. In a ...
Ken Beckman, MD, FACS, is a corneal specialist and clinical assistant professor at The Ohio State University. At the 2025 ...
DAVIO-2 for wet AMD and VERONA for DME. In the DAVIO-2 trial, patients previously treated with approximately 10 injections in ...
In the Phase 2 TEASE 2 trial, gildeuretinol was well tolerated and showed promising trends in slowing ellipsoid zone loss and preserving low-luminance visual acuity in patients with Stargardt disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results